These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Retrolental fibroplasia: a new look at an unsolved problem. Johnson L Hosp Pract (Off Ed); 1981 May; 16(5):109-15, 118-20, 121. PubMed ID: 6785184 [No Abstract] [Full Text] [Related]
25. Persistence and hyperplasia of the primary vitreous (tunica vasulosa lentis or retrolental fibroplasia). REESE AB; PAYNE F Am J Ophthalmol; 1946 Jan; 29():1-24. PubMed ID: 21007770 [No Abstract] [Full Text] [Related]
26. Blood groups and effects of roentgen irradiation in retrolental fibroplasia. PAUL TO Arch Ophthal; 1949 Jun; 41(6):659-66. PubMed ID: 18131743 [No Abstract] [Full Text] [Related]
27. Retrolental fibroplasia; incidence in different localities in recent years and a correlation of the incidence with treatment given the infants. KINSEY VE; ZACHARIAS L J Am Med Assoc; 1949 Feb; 139(9):572-8. PubMed ID: 18123547 [No Abstract] [Full Text] [Related]
28. Current concepts of the effect of oxygen on the developing retina. Patz A Curr Eye Res; 1984 Jan; 3(1):159-63. PubMed ID: 6197238 [TBL] [Abstract][Full Text] [Related]
29. Vitamin E in retrolental fibroplasia. Smith IJ; Buchanan MF; Goss I; Congdon PJ N Engl J Med; 1983 Sep; 309(11):669-70. PubMed ID: 6688460 [No Abstract] [Full Text] [Related]
30. Trial of vitamin E therapy for retrolental fibroplasia. Gunby P JAMA; 1980 Mar; 243(10):1021, 1025. PubMed ID: 6986480 [No Abstract] [Full Text] [Related]
31. Retrolental fibroplasia and vitamin E. Hittner HM Ophthalmology; 1982 Aug; 89(8):987-9. PubMed ID: 6897109 [No Abstract] [Full Text] [Related]
32. Persistence and hyperplasia of primary vitreous; retrolental fibroplasia; two entities. REESE AB Arch Ophthal; 1949 May; 41(5):527-52. PubMed ID: 18128043 [No Abstract] [Full Text] [Related]
33. [Pathology of the retina in prematures (retrolental fibroplasia)]. LELONG M; ROSSIER A; LEMASSON J; MICHELIN J Arch Fr Pediatr; 1951; 8(5):559-61. PubMed ID: 14857819 [No Abstract] [Full Text] [Related]
34. Resistance of red cells to dialuric acid of premature infants with retrolental fibroplasia. COHEN S; DeMETRY JP; HERRMANN H Proc Soc Exp Biol Med; 1951 May; 77(1):134-5. PubMed ID: 14844418 [No Abstract] [Full Text] [Related]
35. Vitamin E and retrolental fibroplasia. Improved visual outcome with early vitamin E. Finer NN; Schindler RF; Peters KL; Grant GD Ophthalmology; 1983 May; 90(5):428-35. PubMed ID: 6348635 [No Abstract] [Full Text] [Related]
36. Retinopathy of prematurity (retrolental fibroplasia). Ho E Midwives Chron; 1989 Aug; 102(1219):260-3. PubMed ID: 2796774 [No Abstract] [Full Text] [Related]
37. Retrolental fibroplasia and vitamin E in the preterm infant--comparison of oral versus intramuscular:oral administration. Hittner HM; Speer ME; Rudolph AJ; Blifeld C; Chadda P; Holbein ME; Godio LB; Kretzer FL Pediatrics; 1984 Feb; 73(2):238-49. PubMed ID: 6546416 [TBL] [Abstract][Full Text] [Related]
38. [Prevention of retrolental fibroplasia by administration of water soluble vitamin E (preliminary report)]. Hervei S; Bors Z; Ugrai M; Malik T; Czappán P; Bohár A; Véli M Orv Hetil; 1983 Apr; 124(14):811-2. PubMed ID: 6346217 [No Abstract] [Full Text] [Related]
39. Retrolental fibroplasia (retinopathy of prematurity). Patz A Trans Ophthalmol Soc N Z; 1980; 32():49-54. PubMed ID: 6934650 [No Abstract] [Full Text] [Related]
40. Vitamin E and retrolental fibroplasia in 1982. Phelps DL Pediatrics; 1982 Sep; 70(3):420-5. PubMed ID: 7050877 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]